Author

Jeroen Michiel Jansen 1

1 Onze Lieve Vrouwe Gasthuis,Amsterdam,Netherlands

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Reinier C. A. van Linschoten, Fenna Minke Jansen, Renske W. M. Pauwels, Lisa J. T. Smits, Femke Atsma, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E. H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Ma

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Fenna Minke Jansen, Reinier C. A. van Linschoten, Renske Wilhelmina Maria Pauwels, Lisa S. Smits, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E.H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Maurice G

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Maurice Russel, Pepijn Thomas, Maarten te Groen, Rachel West, Lisa S. Smits, Jeroen Michiel Jansen, Frank Hoentjen, Tessa E.H. Römkens

INFLUENCE OF ANTIBIOTIC DURATION IN CHOLANGITIS AFTER SUCCESSFUL DRAINAGE BY ERCP

Britt ten Böhmer, Sylke Haal, Sebastiaan Balkema, A.C.T.M. Depla, Paul Fockens, Jeanin E. van Hooft, Jeroen Michiel Jansen, S.D. Kuiken, B.I. Liberov, E van Soest, Rogier P. Voermans

LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERA

Shannon Kanis, Sanne Modderman, Johanna Caroline Escher, Ruud Beukers, K.H.N. (Nanne) de Boer, Alexander Bodelier, ACTM Depla, Gerard Dijkstra, Anne-Baue Van Dijk, Lennard P.L. Gilissen, Frank Hoentjen, Jeroen Michiel Jansen, Johannes Kuijvenhoven, Nofel Mahmmod, R. Mallant, Andrea E. Van Der Meulen - De Jong, Anahita Noruz

LONG-TERM OUTCOME OF THE POINTER RANDOMIZED TRIAL ON IMMEDIATE VERSUS POSTPONED INTERVENTION FOR INFECTED NECROTIZING PANCREATITIS

CL van Veldhuisen, Noor Sissingh, Lotte Boxhoorn, Sven van Dijk, Janneke van Grinsven, Robert C. Verdonk, Marja A. Boermeester, Stefan AW Bouwense, Marco J. Bruno, Vincent Cappendijk, Peter van Duijvendijk, Casper van Eijck, Paul Fockens, Harry van Goor, Muhammed Hadithi, Jan Willem Haveman, Maarten A.J.M. Jacobs, Jeroen M

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Pepijn Thomas, Nathan den Broeder, Rachel West, Maurice Russel, Tessa E.H. Römkens, Frank Hoentjen, Jeroen Michiel Jansen

SIMILAR TRIAL - EFFICACY OF INFLIXIMAB-BIOSIMILAR COMPARED TO INFLIXIMAB-BIOLOGICAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION - A RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE 4 NONINFERIORITY TRIAL

Adrian Geurt Volkers, Jeroen Michiel Jansen

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Tessa Straatmijer, Vince Biemans, Marijn C. Visschedijk, Frank Hoentjen, Annemarie C. de Vries, Adriaan A. Van Bodegraven, Alexander Bodelier, K.H.N. (Nanne) de Boer, Gerard Dijkstra, E.A.M. (Noortje) Festen, Carmen Horjus Talabur Horje, Jeroen Michiel Jansen, Bindia Jharap, Wout Mares, Fiona Van Schaik, Cyriel Y. Ponsioen;;

TRANSANAL ENDOSCOPIC MICROSURGERY VERSUS ENDOSCOPIC MUCOSAL RESECTION FOR LARGE RECTAL ADENOMAS (TREND-STUDY).

Renée M. Barendse, Gijsbert D. Musters, Eelco J. R. de Graaf, Frank J.C. van den Broek, Esther C.J. Consten, Pascal G. Doornebosch, James C.H. Hardwick, Ignace C de Hingh, Christiaan Hoff, Jeroen Michiel Jansen, A.W. M. van Milligen de Wit, George van der Schelling, Erik Jan Schoon, Matthijs P. Schwartz, Bas L.A.M. Weusten,

Item 1 - 10 / 15
1
2